Latest

Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆

Updated 04 Jul 2026 · HPRA open data

Alfasigma S.p.A — Licensed Medicines

10 medicines held by Alfasigma S.p.A on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 10 products held by Alfasigma S.p.A

Medicine	Active substance	Licence holder	Status
Eurartesim 320 mg/40 mg film-coated tablets EU/1/11/716/001-004	Piperaquine phosphate, Dihydroartemisinin	Alfasigma S.p.A	—
Jyseleca 100 mg film-coated tablets EU/1/20/1480/001-002	Filgotinib maleate	Alfasigma S.p.A	—
Jyseleca 200 mg film-coated tablets EU/1/20/1480/003-004	Filgotinib maleate	Alfasigma S.p.A	—
Lumeblue 25 mg prolonged-release tablets EU/1/20/1470/001	Methylthioninium chloride	Alfasigma S.p.A	—
Rifaximin Alfasigma 550 mg film-coated tablets PA2206/001/001	Rifaximin	Alfasigma S.p.A	Not marketed
Synacthen 250 micrograms/ml solution for injection PA2206/002/001	Tetracosactide acetate	Alfasigma S.p.A	Not marketed
Syntocinon Ampoules 10 IU/ml solution for injection/infusion PA2206/003/002	Oxytocin	Alfasigma S.p.A	Not marketed
Syntocinon Ampoules 5 IU/ml solution for injection/infusion PA2206/003/001	Oxytocin	Alfasigma S.p.A	Marketed
Zaditen 1 mg Tablets PA2206/004/002	KETOTIFEN FUMARATE	Alfasigma S.p.A	Marketed
Zaditen 1mg/5ml oral solution PA2206/004/001	Ketotifen hydrogen fumarate	Alfasigma S.p.A	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.